Clinical Trials Logo

Clinical Trial Summary

Salt-sensitive hypertension (SSH) accounts for about the half of all Hypertension (HT) cases .In SSH, Na+/K+-ATPase activity is impaired. Impaired Na+/K+-ATPase activity in the lens epithelium results in cortical opacities in the peripheral equator of the lens.

This study analyzed 305 patients with hypertension aged between 40 and 80 years and 124 non-HT controls. A total of 163 patients with HT who were admitted to the emergency service at least once with a minimum increase of 10% in their systolic and diastolic blood pressure after consuming salted food met the eligible criteria for HT and were included in the SSH group. A total of 142 patients who were previously diagnosed with HT but had no previous history were considered non-SSH. Two researchers examined the presence of cortical lens opacities biomicroscopically using the diffuse, direct, Scheimpflug, and retroillumination from fundus methods.


Clinical Trial Description

The number of patients with hypertension (HT) worldwide is estimated to reach 1.56 billion by 2025.HT accounts for almost 50% of deaths due to stroke and coronary artery disease. Salt-sensitive hypertension (SSH) accounts for about the half of all HT cases. Na+ /K+-ATPase activity is impaired in patients with SSH . Impaired Na+ /K+-ATPase activity in the lens epithelium results in cortical opacities in the peripheral equatorial region of the lens.A definite diagnosis of salt sensitivity is difficult, expensive, and associated with low patient compliance. Salt sensitivity is a risk factor for cardiovascular mortality and morbidity regardless of blood pressure and for other diseases such as asthma, gastric carcinoma, osteoporosis, and renal dysfunction. The present study is the first to investigate the potential of using lens opacity to predict SSH.

The transparency of the whole lens is largely based on epithelial cell permeability and Na+ /K+-ATPase activity. Circulation is activated by Na+ /K+-ATPases, which are present at 20-fold normal concentrations, particularly in the equatorial than in the anterior epithelial cells.

The mechanisms associated with SSH pathogenesis, such as signaling pathways involving Src family kinase (SFK), endothelin, connexin, brain natriuretic peptide (BNP), aldosterone, transient receptor protein V4 (TRPV4) ion channel, with-no-lysine kinase-Ste20-like proline/alanine rich kinase/oxidative stress-responsive kinase 1 (WNK-SPAK/OSR1), and Ras-related C3 botulinum toxin substrate (Rac1) , are important to the physiology of the lens epithelium. Compelling studies suggest that inhibition of these pathways may facilitate opacity. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03385070
Study type Observational [Patient Registry]
Source Kecioren Education and Training Hospital
Contact
Status Completed
Phase N/A
Start date March 15, 2017
Completion date December 7, 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT03688425 - Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes N/A
Active, not recruiting NCT04987216 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Europe (PHY2104) N/A
Completed NCT03297372 - Visual Performance Intraocular Lens (IOL) MicroPure 1.2.3. N/A
Completed NCT01061463 - Occupational Cataracts and Lens Opacities in Interventional Cardiology : the O'CLOC Study N/A
Completed NCT03347981 - Clinical Study to Compare Visual Performance of Two Trifocal IOLs N/A
Withdrawn NCT04054427 - Implantation of a Trifocal Hydrophobic IOL in Patients That Underwent Refractive Surgery N/A
Completed NCT04699266 - Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes N/A
Completed NCT04875455 - Premium Trifocal IOL Comparative Analysis N/A
Active, not recruiting NCT04744467 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) N/A
Recruiting NCT04465344 - Multicentric Clinical Study on Isatis TF Trifocal Intraocular Lens N/A
Active, not recruiting NCT04176965 - Investigation of the Safety and Effectiveness of a Trifocal IOL N/A
Completed NCT04874376 - PMCF Retrospective Study Outcomes of a Premium Monofocal IOL N/A
Active, not recruiting NCT04866719 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Spain N/A
Completed NCT03423524 - Clinical Study to Investigate Visual Performance of a Hydrophobic Monofocal IOL After Bilateral Implantation N/A
Completed NCT05235139 - PMCF Study on Comparison of EDOF Lenses (Switzerland) N/A
Active, not recruiting NCT03844828 - Clinical Study to Investigate Outcomes of Trifocal Toric IOL POD FT in Asian Eyes N/A
Recruiting NCT06105190 - Clinical Study to Evaluate Clinical Outcomes of LuxSmart IOL as Compared With LuxGood IOL N/A
Recruiting NCT05588921 - LensAge to Reveal Biological Age
Completed NCT03974451 - A Comparison of FineVision Intraocular Lenses vs Symfony Intraocular Lenses N/A